AstraZeneca and its development partner Amgen announced that the FDA has granted Breakthrough Therapy Designation (BTD) for tezepelumab in patients with severe asthma, without an eosinophilic ...
Chronic obstructive pulmonary disease (COPD) can result from chronic bronchitis or emphysema. Some people may also have COPD and asthma, which can worsen both conditions. Chronic obstructive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback